Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, BFA, FVT

10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024


PLEASANTON, Calif., Jan. 24, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Thursday, February 15, 2024. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Live audio of the webcast will be available on the "Investors" section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts 
Investors: [email protected] 
Media: [email protected]

SOURCE 10x Genomics, Inc


These press releases may also interest you

at 09:15
The "Infectious Diseases Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access...

at 09:11
Mobile Communications America, Inc. ("MCA"), the leading provider of wireless communication solutions that enhance the safety, security, and operating efficiency of workplaces today, announces the acquisition of LightSpeed Technologies, Inc....

at 09:10
Mosyle, the only Apple Unified Platform, today announced the launch of Mosyle Fuse MSP, the first solution that integrates five critical management and security applications into a single, Apple-only product specifically designed for Managed Service...

at 09:10
FundingShield is pleased to announce that John Hedlund has joined its advisory board. John Hedlund, founder of Adanac Advisory Group (AAG), a boutique advisory and consulting firm, recently retired from AmeriHome Mortgage, a Western Alliance Bank...

at 09:10
Siri's first Head of Product and Design, Mads Rydahl, has funneled his extensive knowledge of AI and Large Language Models (LLMs) into a new company; Proemial. The startup, co-founded by serial entrepreneur Geet Khosla and tech veteran Brian...

at 09:10
Orca Security, the leader in agentless cloud security, today announced significant new capabilities and services that enable rapid investigation and response to cloud-native infrastructure attacks. With the general availability of cloud digital...



News published on and distributed by: